1. Pediatric EBV Positive Mucocutaneous Ulceration in Stomach a Rare Entity
- Author
-
Elvan Caglar Citak, Begümhan Demir Gündoğan, Yusuf Usta, Asuman Nur Karhan, Mehmet Alakaya, Ali Ertug Arslankoylu, Yasemin Yuyucu Karabulut, and Nalan Akyürek
- Subjects
Epstein-Barr Virus Infections ,Herpesvirus 4, Human ,medicine.medical_specialty ,Abdominal pain ,medicine.disease_cause ,Skin Diseases ,hemic and lymphatic diseases ,EBV Positive ,medicine ,Humans ,Oral mucosa ,Child ,Brentuximab vedotin ,Ulcer ,Immunodeficiency ,business.industry ,Stomach ,Hematology ,medicine.disease ,Epstein–Barr virus ,Dermatology ,Lymphoproliferative Disorders ,medicine.anatomical_structure ,Oncology ,Pediatrics, Perinatology and Child Health ,Ataxia-telangiectasia ,medicine.symptom ,business ,medicine.drug - Abstract
Epstein Barr virus (EBV) related lymphoproliferative diseases may occur in immunocompromised patients or patients with a history of drug use causing immunodeficiency. EBV positive mucocutaneous ulceration in the new classification of lymphoproliferative diseases in 2016 is very rare in children. Involvement occurs in the skin, oral mucosa, and gastrointestinal system. Gastric involvement is very rare in the literature. There is no case of gastric involvement in children. There are no specified modalities in the treatment of EBV positive mucocutaneous ulceration. We presented our pediatric patient with ataxia telangiectasia who presented with abdominal pain and difficulty swallowing and diagnosed with EBV positive mucocutaneous ulceration in the stomach. We started brentuximab vedotin during the treatment process, and complete remission was achieved after 6 cures of treatment. Our patient is the first case of EBV positive mucocutaneous ulceration in the pediatric case series.
- Published
- 2021
- Full Text
- View/download PDF